Corcept Therapeutics
CORT
CORT
215 hedge funds and large institutions have $1.38B invested in Corcept Therapeutics in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 78 increasing their positions, 75 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $1.45B → $1.38B (-$69.3M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
67% less call options, than puts
Call options by funds: $8.13M | Put options by funds: $25M
Holders
215
Holding in Top 10
2
Calls
$8.13M
Puts
$25M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$20.4M | |
| 3 | +$7.85M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$6.89M |
| 5 |
KBC Group
Brussels,
Belgium
|
+$5.8M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$11.2M | |
| 3 | -$8.8M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$8.31M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$8.14M |